SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-22-005041
Filing Date
2022-02-14
Accepted
2022-02-14 06:06:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC13G/A brhc10033974_sc13ga.htm SC 13G/A 61693
  Complete submission text file 0001140361-22-005041.txt   63276
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

IRS No.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SC 13G/A

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89552 | Film No.: 22624475
SIC: 2834 Pharmaceutical Preparations